Skip to main content

Biosecurity and national security

Inquiry

Following up the previous Committee’s partially completed inquiry into biosecurity in 2019, and the continued salience of such pandemic risks with Covid-19, the Joint Committee on the National Security Strategy is examining how biosecurity is addressed in national security planning and resilience implementation.

This inquiry is currently accepting evidence

The committee wants to hear your views. We welcome submissions from anyone with answers to the questions in the call for evidence. You can submit evidence until Monday 7 September 2020.

Read the call for evidence before submitting

Reports and government responses

No reports or government responses published

Oral evidence transcripts

No oral evidence transcripts published

Witnesses Doctor Gregory Lewis (Researcher at Future of Humanity Institute, Oxford University)
Committees National Security Strategy (Joint Committee)
Written Evidence
Witnesses Dr Beyza Unal (Senior Research Fellow, International Security Programme at Chatham House), and Mr Ben Wakefield (Research Associate, Global Health Programme at Chatham House)
Committees National Security Strategy (Joint Committee)
Written Evidence
Witnesses Dr Patricia M. Lewis (Research Director, Conflict, Science & Transformation; Director, International Security Programme? at Chatham House - The Royal Institute of International Affairs)
Committees National Security Strategy (Joint Committee)
Written Evidence

Other publications

No other publications published

Contact us

  • Phone: 020 7219 8092/4043 (General / Commons enquiries) / 0207 219 7411 (Lords enquiries)
  • Address: Joint Committee on the National Security Strategy, House of Commons, London, SW1A 0AA